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Abstract Protein biosynthesis is controlled by a number of
proteins external to the ribosome. Of these, extensive structural
investigations have been performed on elongation factor-Tu and
elongation factor-G. This now gives a rather complete structural
picture of the functional cycle of elongation factor-Tu and
especially of the elongation phase of protein biosynthesis. The
discovery that three domains of elongation factor-G are
structurally mimicking the amino-acylated tRNA in the ternary
complex of elongation factor-Tu has been the basis of much
discussion of the functional similarities and functional differences
of elongation factor-Tu and elongation factor-G in their
interactions with the ribosome. Elongation factor-G:GDP is
now thought to leave the ribosome in a state ready for checking
the codon-anticodon interaction of the aminoacyl-tRNA con-
tained in the ternary complex of elongation factor-Tu. Elonga-
tion factor-G does this by mimicking the shape of the ternary
complex. Other translation factors such as the initiation factor-2
and the release factor 1 or 2 are also thought to mimic tRNA.
These observations raise questions concerning the possible
evolution of G-proteins involved in protein biosynthesis.
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1. Introduction
Protein biosynthesis is a central biological process in all
living cells. It is one of the last steps in the transmission of
genetic information stored in DNA on the basis of which
useful active proteins are produced for maintaining the spe-
ci¢c biological function of a given cell. Protein biosynthesis
takes place on ribosomal particles where the genetic informa-
tion transcribed into mRNA is translated into protein. The
ribosome particle itself has been the subject for substantial
scienti¢c investigation for decades and much is therefore
known about its function. Structural studies have recently
provided results which are the prerequisite for obtaining de-
tailed structural information on ribosomal subunits [1,2] and
eventually also on the whole particle in various functional
states within the next few years [3^7].
The process of synthesizing proteins on the ribosome is
divided into three phases: initiation, elongation and termina-
tion. Both initiation and termination are special phases in that
they are directed by speci¢c codons, i.e. the start and stop
codons of mRNA. In prokaryotic biosynthesis, which is the
most studied, the initiation phase is controlled by a small
number of initiation factors (IFs), IF-1, IF-2 and IF-3. Of
these, IF-2 most likely forms a ternary complex with GTP
and initiator tRNAMetf . All three factors are involved in as-
sembling the initiation complex of initiation factors, initiator
tRNAMetf , the ribosomal subunits and mRNA. Eukaryotic
initiation is much more complex and involves a large number
of eukaryotic initiation factors (eIFs) [8^10]. Termination is
controlled by release factors (RFs) which have been exten-
sively studies in recent years [11,12]. In prokaryotes, the
stop codons are speci¢cally recognized by RF1 and RF2,
while a third factor, RF3, in complex with GTP stimulates
the release of the fully synthesized protein from the ribosome.
In eukaryotes, only two factors, eRF1 and eRF3, have been
found.
The elongation phase has been the one phase most exten-
sively studied, both functionally and structurally over the last
30 years [13]. It is controlled by three elongation factors
(EFs). Elongation factor EF-Tu (EF-1K in eukaryotes) forms
a ternary complex with GTP and amino-acylated tRNAs (aa-
tRNAs), protects the amino acid ester bond against hydrolysis
and carries the aa-tRNA to the ribosomal A-site for decoding
of mRNA by codon-anticodon interactions. When correct co-
don-anticodon recognition occurs, GTP hydrolysis on EF-Tu
is stimulated by the ribosome and EF-Tu:GDP is released.
The nucleotide exchange factor EF-Ts (EF-1L in eukaryotes)
converts EF-Tu:GDP into active EF-Tu:GTP. After a proof-
reading step, the aa-tRNA is brought into contact with the
peptidyl-tRNA in the ribosomal P-site, where peptide bond
formation is catalyzed adding one amino acid to the growing
peptide. The last elongation factor EF-G (EF-2 in eukaryotes)
in complex with GTP controls the translocation of tRNAs
and mRNA on the ribosome.
This review will concentrate mostly on the structural studies
of EF-Tu performed for some years in our laboratory. How-
ever, the elongation phase has been studied in other labora-
tories as well and all of this work now provides a rather
complete picture of most of the major functional steps in
the elongation phase of protein biosynthesis.
2. Elongation factor Tu
The functional cycle of EF-Tu is depicted in Fig. 1. EF-Tu
was the ¢rst GTP-binding protein (G-protein) to be structur-
ally investigated. The ¢rst structural details of the GDP-bind-
ing domain (G-domain) of EF-Tu:GDP from Escherichia coli
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 5 6 2 - 1
*Corresponding author. Fax: (45) (8612) 3178.
E-mail: jnb@imsb.au.dk
FEBS 22023 2-6-99 Cyaan Magenta Geel Zwart
FEBS 22023 FEBS Letters 452 (1999) 41^46
Fig. 1. The fFunctional cycle of elongation factor EF-Tu. At the top is the ternary complex of Phe-tRNA:EF-Tu:GDPNP with Phe-tRNA, at
the top left entering the complex (PDB 1ttt [29]). Going round clockwise is the ribosome particle (not to scale), re-drawn after Stark et al. [3].
Next is the EF-Tu:GDP after release from the ribosome (PDB 1tui [18]). At the bottom is EF-Ts entering the complex of EF-Tu:EF-Ts [25]
for nucleotide exchange. Finally, the active EF-Tu:GDPNP is found ready for interacting with aa-tRNA (PDB 1eft [22]). In the middle is
shown EF-G:GDP (PDB 1dar [35]), which in its active form translocates tRNAs on the ribosome. The structural cartoons are drawn using
MOLSCRIPT [56].
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were elucidated in 1985 [14,15] and were soon after used to
formulate a model for the ras p21 protein [16]. Four years
later, it was shown that this model was essentially correct [17].
The structural information now includes the crystal structures
of EF-Tu:GDP from Thermus aquaticus [18] and from E. coli
[18^20], crystal structures of EF-Tu:GDPNP, where GDPNP
is a non-hydrolyzable analogue of GTP, from Thermus ther-
mophilus [21] and from T. aquaticus [22] and models of EF-
Tu:GDP and EF-Tu:GTP from Bacillus stearothermophilus
[23] based on the crystal structures. The crystal structures of
EF-Tu:EF-Ts have been determined both from E. coli [24,25]
and from T. thermophilus [26]. Recently, a solution structure
of a fragment of human EF-1L has been determined revealing
that this eukaryotic EF is structurally related to EF-Ts [27],
but surprisingly even closely related to domains 3 and 5 of
EF-G (see later).
From all this structural information, it is known that EF-
Tu consists of three structural domains. Domain 1 (the G-
domain) of about 200 amino acid residues is binding GDP/
GTP, is a typical nucleotide-binding domain having a central
L-sheet surrounded by K-helices and is found to be similar in
other G-proteins [28]. Domains 2 and 3 of about 100 residues
each are both L-barrels and are in all known structures held
together as one structural unit by strong interdomain interac-
tions. The structures also reveal that EF-Tu is extraordinary
in the sense that the two structural units (domain 1 is one and
domains 2 and 3 together is the other) have large variations in
their relative orientations (Fig. 2). The large di¡erence be-
tween the EF-Tu:GDP and EF-Tu:GTP can be explained
by the di¡erence in structure of two regions on the G-domain
called switch I and switch II. Switch I changes from a L-hair-
pin in EF-Tu:GDP to a short K-helix in EF-Tu:GTP. In
switch II, the K-helix is shifted along the sequence by approx-
imately four residues, thereby rotating the axes of the helix by
about 45‡. Since this helix (termed helix B) is part of the
interface between domains 1 and 3, this explains the large
conformational change of EF-Tu upon its activation. The
change in helix B is directly coupled to the introduction of
a Q-phosphate in the nucleotide-binding site, because this
phosphate induces an almost 180‡ peptide £ip at a conserved
Gly just prior to the K-helix.
The large conformational change must involve a temporary
dissociation between domains 1 and 3 [22]. Such a dissociation
is precisely seen in the EF-Tu:EF-Ts complex [24,25], where
domains 2 and 3 have yet again a third orientation relative to
domain 1 (Fig. 2). Although this is seen to be more similar to
the orientation found in EF-Tu:GDP, it is obvious that the
complex formation allows the two switch regions to assume
any one of the two structures found in EF-Tu:GDP and EF-
Tu:GDPNP. Such information gives the impression that EF-
Tu:GDP is a very £exible complex, whose structure can be
in£uenced by many external factors. This is supported by the
crystallographic observation that in this structure, the temper-
ature factors of domain 2 are generally higher than those of
the other two domains. EF-Tu:GTP seems to be in a much
more ¢xed conformation ready to bind aa-tRNAs.
The structure of the ternary complex of T. aquaticus EF-Tu,
GDPNP and yeast Phe-tRNA [29] showed that the two major
parts in the complex are not much changed upon binding to
each other. The CCA-Phe end of Phe-tRNA in the complex is
bent relative to that of the free tRNA and lies in a narrow
cleft between domains 1 and 2, where the amino acid pocket is
also found. The amino acid ester is held by the backbone of a
loop on the surface of domain 2 and the terminal A-base
snuggles neatly into a narrow cleft with hydrophobic amino
acids on one side and on the other side in a stacking con¢g-
uration with a conserved Glu. There is a rather non-speci¢c
interaction between a surface of domain 3 with one side of the
T-stem helix of Phe-tRNA. The anticodon is pointing away
from EF-Tu, thus creating a very elongated complex. Re-
cently, the structure of a second ternary complex of T. aqua-
ticus EF-Tu, GDPNP and E. coli Cys-tRNA was determined
[30]. The structure is overall very similar to the ¢rst ternary
complex, but reveals the speci¢c features of the tRNA struc-
Fig. 2. Comparison of various functional states of EF-Tu. At the left is EF-Tu:GDPNP (PDB 1eft [22]), in the middle, EF-Tu as found in the
EF-Tu:EF-Ts complex [25] and at the right, EF-Tu:GDP (PDB 1tui [18]). Domain 1 is yellow and domains 2 and 3 are green [28]. Nucleotides
are shown as ball and stick model. Notice the structural changes of switch region I shown in red. The ¢gure has been drawn using MOL-
SCRIPT [56].
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ture. The ternary complex has also been shown to have the
same structure in solution as in the crystals [31].
On the ribosome, the ternary complex is blocked by the
antibiotic kirromycin, such that even after the GTP on EF-
Tu has been hydrolyzed, the EF-Tu:GDP remains bound,
most likely still in a complex with aa-tRNA. Crystals have
been obtained of such a quaternary complex [32] and the
structure determination is underway. The position on the ri-
bosome of the kirromycin-blocked ternary complex has been
revealed by cryo-electron microscopy (cryo-EM) [4]. This
shows the ternary complex at the entrance to the interface
of the two ribosomal subunits with the anticodon of aa-
tRNA pointing deep into the interior of the ribosome. The
G-domain of EF-Tu is found very close to the proposed posi-
tion of the GTPase center of the 50S subunit while domain 2
is in close contact with the 30S subunit. When comparing the
position of tRNA in this structure with that of the tRNA in
the A-site [3,6], it is obvious that the tRNA must turn around
the anticodon helix in order for the CCA-aa end to reach the
A-site and the peptidyl-transferase center of the ribosome.
3. EF-G and macromolecular mimicry
The structures of the nucleotide-free EF-G [33] and of EF-
G:GDP from T. thermophilus [34,35] have been determined.
The structures show that EF-G has ¢ve domains. Domains 1
and 2 are very similar to domains 1 and 2 of EF-Tu apart
from the fact that EF-G has a small all helical insertion in
domain 1. However, the relative orientation of these domains
in inactive EF-G:GDP are the same as in active EF-
Tu:GDPNP. Domains 3 and 5 have folds which are similar
to those of a number of ribosomal proteins [36,37]. Domain 4
is very elongated, is pointing away from the rest of the mol-
ecule and has an unusual fold [33,34].
When the structure of the ternary complex of EF-Tu was
compared to that of EF-G:GDP [29,34], it became obvious
that the shape of domains 3, 4 and 5 of EF-G together are
mimicking the shape of aa-tRNA (Fig. 3). Thus, the two
factors which are controlling the elongation phase of the pro-
tein biosynthesis present themselves to the ribosome in very
similar overall shapes. The structure of EF-G:GTP is not
known at present and it could conceivably be somewhat dif-
ferent from that of EF-G:GDP [38,39]. Nevertheless, the three
C-terminal domains of EF-G most likely still mimic tRNA
and the fact that EF-G:GDP is similar in the overall shape
to that of the ternary complex clearly points to the possibility
that EF-G:GDP on leaving the ribosome is re-shaping its
surroundings so that they form a site suitable for checking
incoming aa-tRNAs for codon-anticodon interactions [40^
42]. The part of EF-G that is mimicking tRNA suggests
that the function of EF-G in translocation is to chase the
newly synthesized peptidyl-tRNA out of the A-site and into
the P-site [43].
This view is supported by cryo-EM observations of EF-G
on the ribosome [7]. EF-G, like EF-Tu, is blocked on the
ribosome by an antibiotic. In the cryo-EM experiment, EF-
G:GTP was blocked by fusidic acid and the protein is seen as
occupying a site very similar to the one for the ternary com-
plex. At least domains 1 and 2 of EF-G are seen to contact
the 50S and 30S subunits, respectively, in the same mannner
as EF-Tu. This is not trivial since all G-proteins of transla-
tion, i.e. also IF-2 and RF3, have been shown to have do-
mains similar to domains 1 and 2 of EF-Tu and EF-G [44].
These therefore can also be expected to have an initial contact
Fig. 3. Comparison of ternary complexes of EF-Tu with EF-G. At the left is Phe-tRNA:EF-Tu:GDPNP (PDB 1ttt [29]), in the middle is Cys-
tRNA:EF-Tu:GDPNP (PDB 1b23 [30]) and to the right is EF-G:GDP (PDB 1dar [35]). The colouring scheme is similar to the one used in
Fig. 2. The special inserted K-helical domain in domain 1 of EF-G is blue, while tRNAs and domains 3, 4 and 5 of EF-G are green. The ¢gure
has been drawn using MOLSCRIPT [56].
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with the ribosome similar to the ones observed for EF-Tu and
EF-G. The fact that the tRNA mimicking part of EF-G in the
cryo-EM result is not as deep into the ribosome by about 10
Aî compared with the aa-tRNA of the ternary complex indi-
cates that the conformation of EF-G:GTP is also di¡erent
from that of EF-G:GDP by a similar amount [39], suggesting
that on GTP hydrolysis, the tRNA mimic of EF-G moves into
the A-site on the 30S subunit.
4. Other translation factors
Much less structural information has been obtained on the
other translation factors. However, structures are known for
IF-1 from E. coli [45] and of the N- and C-terminal fragments
of IF-3 [46]. Many attempts have been made to crystallize IF-
2 or fragments thereof, but until now with very little success.
It has been attempted to localize tRNA mimicking domains
within IF-2 by comparing sequence multiple alignments of
this factor with alignments of EF-Tu and EF-G [47], but
the results are not convincing. Some structural information
has however been obtained of the much more complicated
process of initiation in eukaryotes [8^10]. The structure of
eIF4E, which binds the cap-structure of eukaryotic mRNA,
is known [48] and reveals a speci¢c recognition of the terminal
m7Gppp with some similarity to the recognition of GDP/GTP
in G-proteins. The structure of eIF-5A from Pyrobaculum
aerophilum has also recently been determined [49].
No structural information has as yet been obtained for the
RFs. It is however generally believed that RF1 and RF2
(eRF1) are tRNA mimics [29,41,50], as they have to recognize
speci¢cally the stop codons and because their function can be
suppressed by suppressor tRNAs. The RF3 (eRF3) is a G-
protein and thus believed to be similar to EF-Tu, also in the
sense that it can be isolated as a complex with RF1 (or RF2).
This is supported by extensive work on comparison of amino
acid sequences and molecular genetics studies aimed at deter-
mining the interactions between RF3 and RF1 [50]. It is still
not completely clear whether the ¢nal release of protein from
the ribosome also involves the action of EF-G as a translocase
or whether the RF3:RF1 alone can act both as a ternary
complex bringing water into the peptidyl transferase center
and as a translocase.
5. Conclusions
The way that EF-G is mimicking the ternary complex (or
vice versa), as a citation from a lecture by P. Moore, ‘ought to
tell us something about the ribosomal function. However, it is
not easy to grasp what it is telling us’. The similarity in overall
shape is striking and posesses the question whether there is
some evolutionary relationship between the two [29,39^41,51],
although protein mimicking RNA is an evolutionary event
which has not been dealt with in many evolutionary theories.
That proteins have evolved from ancestral proteins is now
generally accepted and treated in text books. Even cases of
convergent evolution are evident. That RNAs are mimicking
tRNAs is also widely accepted [52,53]. But have some proteins
evolved to replace the function of ancient RNAs by mimick-
ing their shapes?
If this were the situation, one place to look for it is certainly
the ribosomal machinery of the protein biosynthesis or indeed
the biological processes of replication, transcription and trans-
lation, where at present, proteins and RNAs are seen to work
together so intimately. The fundamental concept thus postu-
lates that in ancient evolutionary times, these basic biological
processes were based exclusively on RNA, of which some
acted as ribozymes. It seems logical enough that a gigantic
step forward in evolution could be reached by utilizing the
much more versatile physical, chemical and structural proper-
ties of the 20 amino acids adopted by nature as compared to
the four nucleotides of RNA (and DNA). The logic is some-
what more strained by assuming that ribozymes evolved to
synthesize amino acids, although peptide bond formation on
the ribosome seems to involve RNA-based catalysis. If an
RNA-based machinery had evolved to provide protein syn-
thesis, it is again quite logical that some RNAs were replaced
by proteins and that these, at least as a ¢rst evolutionary
attempt, were mimicking already evolved RNAs. Is the ob-
servable fact that the three C-terminal domains of EF-G are
so similar to tRNA an example of such an early successful
attempt of a protein to mimic RNA?
If one wants to speculate as far as possible, one could
examine the recently determined structure of the ribozyme
of the group I intron [54,55], especially with respect to the
way that RNA helical structures are packed together and the
way that they interact. This is very reminiscent of the way that
domain 3 of EF-Tu, which has a dimension and a shape of a
short piece of RNA helix, recognizes the T-stem helix of
tRNA. More importantly perhaps, domain 2 and ribosomal
protein L14 [37] also have the shapes of RNA helices. Is it
thus a trait of evolution that RNA evolved to recognize RNA,
that protein replaced some RNA by mimicking and by recog-
nizing RNA and that proteins eventually evolved to recognize
other proteins?
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